Studying biomarkers for allergies, asthma, and mast cell disorders
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial collects blood and tissue samples to better understand allergies, asthma, and mast cell conditions. It aims to find markers that could improve diagnosis and treatment. Participation involves donating samples and sharing medical history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a positive allergy test (skin prick or blood test) or are being tested for allergies.
- You have asthma of any severity.
- You have systemic or cutaneous mastocytosis (a rare immune cell disorder).
- You have mast cell activation syndrome or a genetic form of high tryptase (HTalpha).
- You can understand and sign a consent form in French.
- You are not pregnant or breastfeeding, and you are not under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how certain proteins (Transgelin-2, Metallothionein-2, and Ezrin) are associated with asthma. It may help researchers better understand asthma biology and potentially guide future treatments.
This study screens adults to better understand and manage asthma and allergic diseases. It may help identify treatments or management strategies that improve quality of life.
This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.
This study looks at how pollen, climate, and air pollution affect people with seasonal allergies (chronic rhinitis). It aims to see if these factors worsen symptoms and could help improve allergy care.
This study checks whether a new blood test can measure allergy-related immune signals (IgE) in people with known or suspected allergies. If it works well, it could help doctors diagnose and track IgE allergies more easily.
This study is checking how common allergies to certain plants are by using skin prick tests. If you or your child are already coming to the allergy clinic, you might be able to take part.
Hear when a new Allergic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.